title: Necessity of long-term alertness in levodopa-carbidopa intestinal gel infusion for PD patients.
authors.affiliation: Charité-University Medicine Berlin, Department of Neurology, CBF, Germany.
authors.forename: Fabian
authors.initials: F
authors.lastname: Klostermann
authors.affiliation: Charité-University Medicine Berlin, Department of Gastroenterology, Infectiology and Rheumatology, CBF, Germany.
authors.forename: Christian
authors.initials: C
authors.lastname: Bojarski
authors.affiliation: Charité-University Medicine Berlin, Department of Neurology, CBF, Germany.
authors.forename: Frank
authors.initials: F
authors.lastname: Marzinzik
authors.affiliation: Charité-University Medicine Berlin, Department of Neurology, CBF, Germany.
authors.forename: André
authors.initials: A
authors.lastname: Maier
authors.affiliation: Charité-University Medicine Berlin, Department of Neurology, CBF, Germany.
authors.forename: Katharina A
authors.initials: KA
authors.lastname: Schindlbeck
authors.affiliation: Charité-University Medicine Berlin, Department of Neurology, CBF, Germany.
authors.forename: Felicitas
authors.initials: F
authors.lastname: Ehlen
mesh_terms: D000368:Aged; D000978:Antiparkinson Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D002230:Carbidopa / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D004338:Drug Combinations; D004381:Duodenal Ulcer / Q000150:complications / Q000473:pathology; D005260:Female; D005774:Gastrostomy; D006801:Humans; D007263:Infusions, Parenteral; D007422:Intestines; D007980:Levodopa / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D010300:Parkinson Disease / Q000150:complications / Q000188:drug therapy*
chemical_list: D000978:Antiparkinson Agents; D004338:Drug Combinations; C009265:carbidopa, levodopa drug combination; D007980:Levodopa; D002230:Carbidopa